Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Chouaid

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2020
Monitoring Subsolid Pulmonary Nodules in High-Risk Patients Is Even More Cost-Effective When Combined With a Stop-Smoking ProgramSébastien Gendarme, Christos Chouaid
Expert Review of Pharmacoeconomics & Outcomes Research|December 11, 2020
Economic analyses of immune-checkpoint inhibitors to treat lung cancerAlain Vergnenegre, Christos Chouaid
Targeted Oncology|October 30, 2017
Author's Reply to Arnaud Uguen: "Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study)"Jean-Bernard Auliac, Christos Chouaid
BMC Medicine|January 20, 2011
Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic reviewKokuvi Atsou, Christos Chouaid, Gilles Hejblum
Plos One|September 28, 2011
Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary diseaseKokuvi Atsou, Christos Chouaid, Gilles Hejblum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Targeted therapies in non-small-cell lung cancer management: no cost-effective strategies?Christos Chouaid, Isabelle Borget, Alain Vergnenegre
The Lancet. Oncology|December 3, 2020
Carboplatin plus etoposide for sensitive relapsed small-cell lung cancer - Authors' replyChristos Chouaid, Isabelle Monnet, Nathalie Baize
Clinical Lung Cancer|November 12, 2025
Response to the Letter of Mehmet Mutlu Çatlı, Arif Hakan ÖnderAntoine Bronstein, Olivier Bylicki, Christos Chouaid
Respiratory Research|September 3, 2011
Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspectsChristine Raynaud, Nicolas Roche, Christos Chouaid
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2013
Reply to N. Singh et alMaurice Pérol, David Pérol, Christos Chouaid
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2020
Monitoring Subsolid Pulmonary Nodules in High-Risk Patients Is Even More Cost-Effective When Combined With a Stop-Smoking ProgramSébastien Gendarme, Christos Chouaid
Expert Review of Pharmacoeconomics & Outcomes Research|December 11, 2020
Economic analyses of immune-checkpoint inhibitors to treat lung cancerAlain Vergnenegre, Christos Chouaid
Targeted Oncology|October 30, 2017
Author's Reply to Arnaud Uguen: "Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study)"Jean-Bernard Auliac, Christos Chouaid
BMC Medicine|January 20, 2011
Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic reviewKokuvi Atsou, Christos Chouaid, Gilles Hejblum
Plos One|September 28, 2011
Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary diseaseKokuvi Atsou, Christos Chouaid, Gilles Hejblum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Targeted therapies in non-small-cell lung cancer management: no cost-effective strategies?Christos Chouaid, Isabelle Borget, Alain Vergnenegre
The Lancet. Oncology|December 3, 2020
Carboplatin plus etoposide for sensitive relapsed small-cell lung cancer - Authors' replyChristos Chouaid, Isabelle Monnet, Nathalie Baize
Clinical Lung Cancer|November 12, 2025
Response to the Letter of Mehmet Mutlu Çatlı, Arif Hakan ÖnderAntoine Bronstein, Olivier Bylicki, Christos Chouaid
Respiratory Research|September 3, 2011
Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspectsChristine Raynaud, Nicolas Roche, Christos Chouaid
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2013
Reply to N. Singh et alMaurice Pérol, David Pérol, Christos Chouaid
Pageof 21